Intracavitary radiotherapy with Cf-252 for uterine cervical carcinomas at the Japan Cancer Institute Hospital

Journal Article · Wed Jan 01 04:00:00 EST 1986 · Nucl. Sci. Appl.; (United States)

OSTI ID:6698722

Fukuda, F; Masubuchi, K; Kaneta, K; Tsuya, A; Irifune, I; Onai, Y

Cf-252 intracavitary radiotherapy using a specially designed remote afterloading system and treatment facility was performed in patients with stage IIB and IIIB cervical carcinoma. Cf-252 was effective for both squamous cell carcinoma and adenocarcinoma. For stage IIB 7/7 (100%) had local control, 1/7 (14%) injury, and 6/7 (85%) had long term survival NED. For stage IIIB disease 3/11 (27%) had local control and long term survival. With the varying doses and treatment protocols used, complications were noted, mostly recto-sigmoid. Further study of Cf-252 use in cervix cancer and of its effect on the recto-sigmoid mucosa is required. Both local control and long-term survival (--5 year) were obtained using Cf-252 intracavitary therapy.

• Research Organization: Departments of Gynecology and Radiology, Cancer Institute Hospital, Tokyo
• OSTI ID: 6698722
• Journal Information: Nucl. Sci. Appl.; (United States), Journal Name: Nucl. Sci. Appl.; (United States) Vol. 2:3; ISSN NSAPD
• Country of Publication: United States
• Language: English

Related Subjects

550603* -- Medicine-- External Radiation in Therapy-- (1980-)
550604 -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ACTINIDE ISOTOPES
ACTINIDE NUCLEI
ALPHA DECAY RADIOISOTOPES
ANIMAL CELLS
ASIA
BODY
BUILDINGS
CALIFORNIUM 252
CALIFORNIUM ISOTOPES
CARCINOMAS
DISEASES
EVEN-EVEN NUCLEI
FEMALE GENITALS
HEAVY NUCLEI
HOSPITALS
ISOTOPES
JAPAN
LOADING
MATERIALS HANDLING
MEDICAL ESTABLISHMENTS
MEDICINE
NEOPLASMS
NEUTRON THERAPY
NUCLEAR MEDICINE
NUCLEI
ORGANS
PATIENTS
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
REMOTE HANDLING
SURVIVAL TIME
THERAPEUTIC USES
THERAPY
USES
UTERUS
YEARS LIVING RADIOISOTOPES